How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
1 天on MSN
New enzyme network with competing peptides can make decisions based on external environment
The ability to respond to changing surroundings was once considered exclusive to complex living organisms. Then came ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果